Listed

Petmed Express Inc

PETSNasdaqCIK 1040130Consumer staplesFiscal year ends Mar 31

Reports and events: 393 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Petmed Express Inc, Reports and events
FiledFormWhat it isAccession number
2024-08-0516:27 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-24-000062
2024-06-2411:00 ETDEF 14AProxy statementPeriod 2024-08-080001040130-24-000050
2024-06-2408:09 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-24-000048
2024-06-1408:30 ET10-KAnnual reportPeriod 2024-03-310001040130-24-000046
2024-06-1116:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001040130-24-000043
2024-05-3117:24 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001040130-24-000032
2024-05-2013:42 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-24-000028
2024-04-2908:17 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-24-000022
2024-04-1508:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001040130-24-000020
2024-04-1508:13 ET10-QQuarterly reportPeriod 2023-12-310001040130-24-000019
2024-04-1508:12 ET10-Q/AQuarterly report, amendedPeriod 2023-09-300001040130-24-000018
2024-04-1508:10 ET10-Q/AQuarterly report, amendedPeriod 2023-06-300001040130-24-000017
2024-04-1508:06 ET10-K/AAnnual report, amendedPeriod 2023-03-310001040130-24-000016
2024-02-1511:20 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001040130-24-000010
2024-02-0816:03 ET8-K2.02 Results of operations; 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-24-000004
2024-01-0816:04 ET8-K8.01 Other events0001040130-24-000002
2023-10-3116:27 ET10-QQuarterly reportPeriod 2023-09-300001040130-23-000080
2023-10-3016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001040130-23-000078
2023-08-0414:08 ET8-K5.07 Shareholder vote results0001040130-23-000062
2023-08-0218:17 ET10-QQuarterly reportPeriod 2023-06-300001040130-23-000052
2023-07-3116:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-23-000049
2023-06-2014:16 ETDEF 14AProxy statementPeriod 2023-08-030001040130-23-000044
2023-06-2010:34 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001040130-23-000040
2023-05-2613:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001040130-23-000036
2023-05-2308:40 ET10-KAnnual reportPeriod 2023-03-310001040130-23-000033
2023-05-2216:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-23-000027
2023-05-1921:50 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-23-000023
2023-04-0314:14 ET8-K7.01 Regulation FD disclosure; 8.01 Other events0001040130-23-000020
2023-02-0817:57 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001040130-23-000015
2023-02-0717:26 ET10-QQuarterly reportPeriod 2022-12-310001040130-23-000013
2023-02-0616:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-23-000011
2023-01-1909:06 ET8-K7.01 Regulation FD disclosure0001040130-23-000007
2023-01-1715:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-23-000003
2022-11-0808:54 ET10-QQuarterly reportPeriod 2022-09-300001040130-22-000008
2022-11-0716:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-22-000006
2022-08-0316:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-22-018636
2022-08-0213:36 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-22-018367
2022-08-0210:44 ET10-QQuarterly reportPeriod 2022-06-300001437749-22-018341
2022-07-2915:57 ET8-K5.07 Shareholder vote results0001437749-22-018136
2022-07-2715:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-017871
2022-07-2613:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-017750
2022-07-1808:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-017228
2022-07-1416:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-22-017145
2022-07-1116:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-016960
2022-06-1715:16 ETDEF 14AProxy statementPeriod 2022-07-280001437749-22-015277
2022-05-2417:23 ET10-KAnnual reportPeriod 2022-03-310001437749-22-013417
2022-05-1210:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-012031
2022-05-1015:33 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-011707
2022-05-1012:37 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-011659
2022-05-0308:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-010583

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 14:26 ET. Listed shows no prices and gives no investment advice.